BG
GH icon

Bellevue Group’s Guardant Health GH Stock Holding History

Bellevue Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,004
Closed -$307K – 172
2025
Q4 		$307K Buy
3,004
+1,051
+54% +$94K 0.01% 147
2025
Q3 		$122K Buy
+1,953
New +$106K ﹤0.01% 137
2023
Q4 		– Sell
-74,525
Closed -$2.21M – 168
2023
Q3 		$2.21M Sell
74,525
-7,672
-9% -$270K 0.04% 112
2023
Q2 		$2.94M Hold
82,197
– – 0.04% 108
2023
Q1 		$1.93M Sell
82,197
-53,258
-39% -$1.52M 0.03% 116
2022
Q4 		$3.68M Buy
135,455
+73,372
+118% +$3.36M 0.05% 116
2022
Q3 		$3.34M Sell
62,083
-8,497
-12% -$436K 0.05% 114
2022
Q2 		$2.85M Sell
70,580
-139,132
-66% -$6.89M 0.04% 120
2022
Q1 		$13.9M Sell
209,712
-83,900
-29% -$5.74M 0.16% 102
2021
Q4 		$29.4M Sell
293,612
-46,282
-14% -$4.79M 0.3% 88
2021
Q3 		$42.5M Sell
339,894
-39,715
-10% -$4.72M 0.43% 73
2021
Q2 		$47.1M Buy
379,609
+76,743
+25% +$10.3M 0.46% 69
2021
Q1 		$46.2M Buy
302,866
+123,625
+69% +$18.7M 0.49% 65
2020
Q4 		$23.1M Buy
179,241
+16,858
+10% +$1.94M 0.26% 95
2020
Q3 		$18.2M Buy
162,383
+35,822
+28% +$3.28M 0.25% 93
2020
Q2 		$10.3M Buy
126,561
+21,267
+20% +$1.71M 0.15% 107
2020
Q1 		$7.33M Sell
105,294
-4,842
-4% -$372K 0.14% 101
2019
Q4 		$8.61M Buy
110,136
+15,375
+16% +$1.11M 0.14% 100
2019
Q3 		$6.05M Sell
94,761
-25,087
-21% -$2.21M 0.11% 103
2019
Q2 		$10.3M Buy
119,848
+10,196
+9% +$779K 0.18% 84
2019
Q1 		$8.41M Buy
109,652
+535
+0.5% +$29.7K 0.46% 61
2018
Q4 		$4.1M Buy
+109,117
New +$4.02M 0.27% 74

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bellevue Group's GH Position: Q1 2026 in Review

Bellevue Group sold out of Guardant Health (GH) in Q1 2026, closing a stake of 3,004 shares — an estimated $307K sold.

Bellevue Group first reported a position in GH in Q4 2018 and held it in 22 quarters. The position peaked at $47.1M in Q2 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Bellevue Group reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Bellevue Group sold 3,004 Guardant Health shares in Q1 2026, an estimated $307K.
  • Bellevue Group first reported a position in Guardant Health in Q4 2018 and held it in 22 quarters.
  • Bellevue Group's Guardant Health position peaked at $47.1M in Q2 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.